Companies: 10,795·Total market cap: $144.5T
Artivion, Inc.

Artivion, Inc.

AORTNYSEHealthcare● Active
$20.26
+$0.14(+0.70%)
Market Cap$983487258
P/E Ratio
52W High$48.25
52W Low$19.16

Artivion, Inc. (AORT) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

aort · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 12 Wall Street analysts in the past 3 months

SellBuy

Buy

12 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
10
Hold
2
Sell
0
Strong Sell
0
Total: 12 · Buy rate: 83.3%

12-Month Price Target

High

$51.00

Consensus

$48.00

+137.1% upside

Low

$45.00

Median: $48 · Last Close: $20.25

The Artivion, Inc. (AORT) analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month AORT price target is $48.00, representing +137.1% upside from the current price of $20.25.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $48 (137.1%)

Consensus Target

$48.00

137.1% upside

High Target

$51

151.9%

Low Target

$45

122.3%

Current Price

$20.25

as of today

Based on analyst price targets, the AORT stock price prediction for the next 12 months ranges from $45 to $51. The consensus AORT price forecast of $48.00 implies 137.1% upside from the current price of $20.25.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$19.235.00%

1-day model range: $18.96–$19.51. Peak: $19.51 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$23+13.1%
2028$25+21.2%
2029$26+26.0%
2030$26+28.8%
2031+30.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%0%93%
1Buy
0Neutral
13Sell
RSI (14)21.9Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · AORT · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$20.44SELL
MA 10$21.40SELL
MA 20$22.16SELL
MA 50$30.41SELL
MA 100$34.65SELL
MA 200$39.26SELL
Current $AORT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$20.59SELL
EMA 10$21.34SELL
EMA 20$23.42SELL
EMA 50$28.51SELL
EMA 100$32.78SELL
EMA 200$35.05SELL
Current $AORT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Needham2026-05-08
Maintains
BuyBuy
Citizens2026-05-08
Maintains
Market OutperformMarket Outperform
Ladenburg Thalmann2026-04-10
Upgrade ↑
NeutralBuy
Needham2026-04-07
Maintains
BuyBuy
Canaccord Genuity2026-02-13
Maintains
BuyBuy
Needham2026-02-02
Maintains
BuyBuy
Citizens2025-11-07
Maintains
Market OutperformMarket Outperform
Canaccord Genuity2025-11-07
Maintains
BuyBuy
Needham2025-11-07
Maintains
BuyBuy
JMP Securities2025-10-10
Maintains
Market OutperformMarket Outperform

Wall Street analysts have recently issued updated ratings on Artivion, Inc. (AORT) stock. Of the recent 67 rating actions, 4 were upgrades and 3 were downgrades. 12 analysts currently cover AORT.

Analyst Recommendation Trends

Buy ratings22
Hold ratings00
Sell ratings00

AORT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$486M

↓ 19.1% YoY

Revenue Next Year

$540M

↑ 11.0% YoY

EPS This Year

$0.14

EPS Next Year

$0.45

↑ 219.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AORT EPS of $0.14 for the current fiscal year, based on estimates from 5 analysts. The AORT revenue forecast is $486M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AORT stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AORT price target is $48.00 (+137.1% upside), with an analyst consensus of Buy.

The AORT short-term stock prediction for tomorrow is $19.23 (-5.00%). The AORT stock price prediction for 2027 estimates an average of $23. The AORT stock prediction for 2030 projects a range of $23–$29.

Artivion, Inc. trades on NYSE under the ticker AORT. The AORT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AORT forecast · 8 questions

According to 12 Wall Street analysts, the average 12-month AORT price target is $48.00, with a high forecast of $51.00 and a low of $45.00. The median price target is shown in the chart above when available. This implies +137.1% potential upside from the current price of $20.25.

AORT price targetWhat is AORT price targetAORT analyst price targetAORT 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.